Kura Oncology, Inc. (KURA)

Kura Oncology Revenue

In the year 2025, Kura Oncology had annual revenue of $67.48M with 25.24% growth. Kura Oncology had revenue of $17.34M in the quarter ending December 31, 2025, a decrease of -67.83%.

• Revenue (ttm): $67.48M
• Revenue Growth: +25.24%
• P/S Ratio: 12.51
• Revenue / Employee: $259,546
• Employees: 260
• Market Cap: 844.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	67.48M	13.60M	25.24%
Dec 31, 2024	53.88M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 12, 2026

Data Sources Report a data error